A
Arvinas D
D
ARVN
7.70000
USD
0.49
(6.72%)
مغلق
حجم التداول
352,002
الربح لكل سهم
-2
العائد الربحي
-
P/E
-3
حجم السوق
562,033,703
الأخبار المقالات
العنوان: Arvinas
القطاع: Healthcare
الصناعة: Biotechnology
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.